INMB
INmune Bio·NASDAQ
--
--(--)
--
--(--)
1.17 / 10
Underperform
Technical evaluation yields a 1.17/10 composite score, denoting challenging technical structure. Optimistic indicators comprise no significant factors, while Long Lower Shadow and MACD Death Cross warrant caution. The technical perspective remains cautious.
Analysis Checks(0/2)
Long Lower Shadow
Score1/10
Win Rate39.62%
Hist. Signals53
Avg Return-1.66%
Score1/10
Win Rate39.62%
Hist. Signals53
Avg Return-1.66%
MACD Death Cross
Score1.34/10
Win Rate37.50%
Hist. Signals8
Avg Return-1.04%
Score1.34/10
Win Rate37.50%
Hist. Signals8
Avg Return-1.04%
Long Lower Shadow
Score1/10
Win Rate39.62%
Hist. Signals53
Avg Return-1.66%
Score1/10
Win Rate39.62%
Hist. Signals53
Avg Return-1.66%
MACD Death Cross
Score1.34/10
Win Rate37.50%
Hist. Signals8
Avg Return-1.04%
Score1.34/10
Win Rate37.50%
Hist. Signals8
Avg Return-1.04%
What is the current technical signals for INMB?
- INMB presents a Underperform setup with a Technical Score of 1.17/10. Key technical indicators highlight an RSI of 44.00 and a MACD of -0.03, with the trend anchored by the 50-Day SMA at 1.70. Traders should monitor key support at 1.38 and resistance at 1.48.
